REPROCELL News

Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services.

Continue reading →

Drug Discovery news, Cancer Research, Preclinical